The effect of gamma knife radiosurgery for cranial base meningiomas was analyzed using magnetic resonance (MR) imaging in 33 patients followed up for a mean 26.5 months. There were 10 male and 23 female patients aged from 38 to 87 years (mean 54.5 yrs). Twenty-three patients had already had more than one open surgery before radiosurgery.
Introduction
Meningiomas are benign tumors which constitute ap proximately 15-20% of intracranial neoplasms.12,13) Complete surgical removal using microsurgical tech niques is the most effective treatment '10,14,15) but total removal of meningiomas at the cranial base is difficult without causing neurological deficits. Frac tionated radiation therapy is beneficial for the treat ment of partially resected meningiomas'"3,6,7,",", 19) and recent reports have shown that stereotactic radiosurgery for meningiomas is also effec tive. 4,s,s,9,16,1s)
Here we report our results of treatment of patients with cranial base meningioma by radiosurgery using the Leksell gamma unit.
Materials and Methods
Thirty-three patients with cranial base meningiomas were treated with the gamma knife (Elekta Instru ments, Stockholm, Sweden) between May 1991 and November 1992. The patients were aged from 38 to 87 years (mean 54.5 yrs). There were 23 females and 10 males. The meningiomas were located in the ten torial region in 17 cases, in the parasellar region in eight, in the olfactory groove in three, in the sphenoidal ridge in two, at the clivus in two, and in the middle cranial fossa in one case. The neurologi cal signs and symptoms were cranial nerve pareses in 26 patients, hemiparesis in three, and cerebellar signs in two. Twenty-three patients had already had at least one craniotomy before radiosurgery. The diagnosis in the other 10 patients was based on com puted tomography (CT), magnetic resonance (MR) imaging, and angiography. The mean volume of the meningiomas was 16.8 cm3 (range 0.7-33 cm3). Four patients with large tumors (>20 cm) were treated by two-stage radiosurgery at 1 to 4-month intervals.
The Leksell G frame was applied under local anesthesia and MR images (short repetition time) with gadolinium enhancement using 3-mm slices were taken to define the tumor margin. Dose plan ning was performed on a MicroVax Computer (Digi tal Equipment Corp., Westminster, Mass., U.S.A.). The marginal dose, usually at the 50% or greater iso dose line, was selected on the basis of tumor size (volume) and location. Follow-up MR imaging and neurological examinations were scheduled at 3 month intervals after radiosurgery. 
Results
The mean maximum dose was 29 Gy (range 24-37.5 Gy) and the mean marginal dose was 15.1 Gy (10-18 Gy). The mean follow-up period was 26.5 months (range 10-34 mos).
Follow-up MR imaging revealed a decrease of tumor size (about 20%) in 10 patients, a small low in tensity area that suggested tumor center necrosis in three, an increase of tumor size in two, and no change in 18. Follow-up of neurological signs and Case 1: This 40-year-old female had already had two craniotomies before radiosurgery for malignant meningioma. The 28-cm3 tumor was located in the in tra and suprasellar regions. The first radiosurgery ir radiated the upper part of the tumor with a marginal dose of 12 Gy using the 40% isodose curve (Fig. IA) . The second treatment was performed 4 months later for the lower part of the tumor with the same mar ginal dose (Fig. 1B) . Follow-up MR images 12 and 23 months after the first treatment revealed marked decrease of the tumor size (Fig. 1C-F) . Case 2: This 42-year-old female had had two craniotomies before radiosurgery for meningothelial meningioma. The 33-cm3 tumor was located in the prepontine cistern and suprasellar region. The lower portion of the tumor was irradiated with a 10-Gy marginal dose at the 45% isodose curve ( Fig. 2A) . The second irradiation of the upper part of the tumor 1 month later used the same marginal dose (Fig. 2B) . Follow-up MR imaging showed a small low intensity area in the tumor center at 9 months and a slight decrease of the tumor size 21 months after the first treatment (Fig. 2C-E) .
Discussion
Meningioma is a benign and slow growing tumor, so the goal of therapy is total surgical excision. The re cent developments of neuroradiological imaging such as CT and MR imaging, and microsurgical tech niques have decreased the recurrence rate of menin giomas after surgery. Mirimanoff et al. 10) reported that, following total resection, the recurrence-free rates at 5, 10, and 15 years were 93%, 80%, and 68%, respectively, at all sites. In contrast, after a subtotal resection, the progression-free rates were only 63%, 45%, and 9% at the same intervals.
However, Bataini et al.') showed that meningiomas from the cranial base were associated with the highest rate of tumor recurrence, especially those growing in the clinoidal and spheno-cavernous areas. Sekhar et al.'s) found considerable progress in the surgical management of patients with intracavernous neo plasms, resulting in successful surgical removal of most cavernous sinus neoplasms. Samii et al.") also reported that "total" removal in surgery of petro clival meningiomas was achieved in 17 patients (71 %). However, 11 patients (46%) suffered postop erative complications, mainly in the form of cranial nerve deficits. In our series, 23 patients had been treated by craniotomy and almost all patients had developed new neurological deficits after surgery.
Conventional fractionated radiation therapy may be of value for residual meningiomas.1,6,7,11,17,19) Taylor et al. 17) reported that the recurrence rate after subtotal resection alone was 69%, which was re duced to 15% by postoperative radiation therapy us ing the single fraction method. Patients who received surgery alone for recurrent meningiomas achieved a local control rate of 30% after 10 years, whereas patients who received additional radiation after re section had a local control rate of 89%.17) Carella et a1.3) and others ', 6,7,11,17,19) also showed that radia tion therapy by the single fraction method has an established role in the treatment of incompletely ex cised, recurrent, or malignant meningiomas, and in some cases, as the initial management of menin giomas.
Initial experience with stereotactic radiosurgery has recently been reported. 4,5,8,9,16, 11) Kondziolka et al.') found that stereotactic radiosurgery was a rela tively safe and effective therapy for selected patients with symptomatic meningiomas, including those who could not undergo surgical resection. Radiosur gery was an effective alternative primary treatment for patients whose advanced age, medical condition, or high-risk locations contraindicated surgical resec tion. Four of 26 patients evaluated between 6 and 12 months after treatment showed a decrease in tumor size, and 22 showed no change. Steiner et al. 16 ) sug gested that remnants of meningioma left after microsurgery should be treated by radiosurgery. The follow-up period in our study was quite short, but MR imaging showed a decrease in tumor size in 10 patients and no change in 21 including small central necrosis areas at 10-34 months after irradiation. There was marked tumor shrinkage after the treat ment in one patient (Case 1) with malignant menin gioma. Coffey et al. 4) also found that radiosurgery ap peared to cause dramatic early shrinkage of small and medium size intracranial hemangiopericytomas which had recurred or developed after previous sur gery and/or radiation therapy.
Single-session radiosurgery might not be indicated for large volume tumors of more than 10 cm3, so we tried two-stage radiosurgery in four patients with large tumors of more than 20 cm3. They had previous ly had craniotomies before radiosurgery and refused further open surgery. One patient (Case 1) showed marked shrinkage in tumor size and another (Case 2) had a low intensity area in the tumor center and slight shrinkage of tumor size. Their neurological signs and symptoms were also improved. Only one of the four patients treated by two-stage radiosur gery showed marked edema around the tumor. In this patient the interval between the first and second treatments was about 2 months, suggesting that the interval in two-stage radiosurgery is important. Peritumoral edema tends to appear after about 3 months, so the second irradiation should be done at least 3 months after the first. Kondziolka et al. ') found that three patients developed neurological deficits between 3 and 12 months after radiosurgery with the gamma knife. Engenhart et al.') also report ed late severe side effects after stereotactic radiation by a linear accelerator including five patients with a large area of brain edema, three of which were con current with tumor necrosis. Four of our patients had deterioration of neurological signs and sym ptoms, which were due to tumor growth in two 
